**Core Concept**
The hexose monophosphate shunt (HMP shunt), also known as the pentose phosphate pathway, is a metabolic pathway that generates NADPH and pentoses from glucose-6-phosphate. It plays a crucial role in biosynthetic reactions, antioxidant defenses, and lipid metabolism.

**Why the Correct Answer is Right**
Glucose-6-phosphate dehydrogenase (G6PD) is the first committed step in the HMP shunt, catalyzing the conversion of glucose-6-phosphate to 6-phosphogluconolactone, producing NADPH in the process. This enzyme is essential for maintaining the cellular redox balance and is particularly important in erythrocytes, where it protects against oxidative damage. G6PD is also involved in the synthesis of nucleotides and fatty acids, as well as the detoxification of xenobiotics.

**Why Each Wrong Option is Incorrect**

* **Option A:** Glucose-6-phosphatase is an enzyme involved in gluconeogenesis and glycogenolysis, catalyzing the conversion of glucose-6-phosphate to glucose. It is not associated with the HMP shunt.
* **Option B:** Phosphorylase is a family of enzymes involved in glycogenolysis, catalyzing the breakdown of glycogen to glucose-1-phosphate. This enzyme is not directly related to the HMP shunt.
* **Option C:** Aldolase is an enzyme involved in glycolysis, catalyzing the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. It is not part of the HMP shunt.

**Clinical Pearl / High-Yield Fact**
G6PD deficiency, a genetic disorder caused by mutations in the G6PD gene, is a common cause of hemolytic anemia in individuals from certain ethnic backgrounds. This deficiency can be triggered by exposure to certain medications, foods, or infections, leading to acute hemolysis.

**✓ Correct Answer: D. Glucose-6-phosphate dehydrogenase**